Windlas Biotech shares were available for trading at a premium of Rs 65 or 14.1 percent in the grey market
After the IPO last week, Windlas Biotech is all set to finalize the allotment of its shares to all the applicant investors on 11th August. The company is one of the top brands in terms of revenue in the domestic pharma formulations contact development.
The IPO of the pharma giant was subscribed 22.47 per cent and received a positive response from investors. The company was able to channel Rs 401.53 crores through the issue.
The company plans to utilize the raised capital for expansion of capacity at its Dehradun plant and for fulfilling its working capital requirements. As per the company’s Draft Red Herring Prospectus, the company is set to finalize the allotment of shares today on 11th August.